![]() Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. | ![]() Longeveron Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations London, GB HQ London, GB | Locations Miami, US HQ |
Employees | Employees 647 | Employees 259% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 31.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) $1.2m (FY, 2025) |
Cost of goods | Cost of goods $86.6m (FY, 2025) | Cost of goods $396k (FY, 2025) |
Gross profit | Gross profit ($10.7m) (FY, 2025) | Gross profit $803k (FY, 2025) |
Net income | Net income ($287.5m) (FY, 2025) | Net income ($22.7m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 281.7m | Total funding raised $ 9m |

Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases.
View company